DOP026 Efficacy and safety of dose escalation to tofacitinib 10 mg BID for patients with ulcerative colitis following loss of response on tofacitinib 5 mg BID maintenance therapy: results from OCTAVE open
暂无分享,去创建一个
B. Sands | J. Lindsay | G. Chan | J. Marshall | W. Sandborn | S. Danese | G. Friedman | A. Armuzzi | C. Su | N. Lawendy | Haiying Zhang | A. Moss | D. Krichbaum | Konstantinos Tsilkos